Adial Pharmaceuticals, Inc.
Pharmaceutical company · Charlottesville, Virginia, United States · Nasdaq: ADIL
Adial Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Charlottesville, Virginia, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker ADIL. It has reported private securities offerings to the US SEC, most recently $4.3 million sold in a notice filed in 2025.
Adial Pharmaceuticals at a glance
What does Adial Pharmaceuticals do?
Private fundraising reported to the SEC
19 Form D notices; the most recent reported $4.3 million sold (2025).
Frequently asked questions about Adial Pharmaceuticals
Where is Adial Pharmaceuticals headquartered?
Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia, United States.
What does Adial Pharmaceuticals do?
Adial Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Adial Pharmaceuticals a public company?
Yes. Adial Pharmaceuticals, Inc. trades on Nasdaq under the ticker ADIL.
When was Adial Pharmaceuticals founded?
The earliest incorporation on record for Adial Pharmaceuticals, Inc. is in 2017, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.